NCT03018275View on ClinicalTrials.gov

Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

October 11, 2019

Study Completion Date

October 11, 2019

Conditions
Atopic Dermatitis
Interventions
BIOLOGICAL

Roseomonas mucosa

R mucosa grown in Hank's balanced salt solution. Bacteria is washed, quantitated spectrophotometrically, suspended in 10%-15% sucrose, and lyophilized.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03018275 - Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis | Biotech Hunter | Biotech Hunter